Hjalmarson A, Källfelt B, Swedberg K, Waagstein F, Waldenström A
Acta Med Scand Suppl. 1983;672:85-93. doi: 10.1111/j.0954-6820.1983.tb01618.x.
It is known that the heart will adapt to actual demand by increasing or decreasing its size through different mechanisms. In this presentation, the possible role of catecholamines in regulating heart protein synthesis and developing cardiac hypertrophy and cardiomyopathy is discussed. Injecting animals with catecholamines has been found to induce cardiac hypertrophy. In vitro perfusion of rat heart in the presence of catecholamines has been found to induce a time-dependent and dose-dependent stimulation of amino acid transport and incorporation into proteins. Acute haemodynamic effects of catecholamines increase cardiac performance while long-term treatment seems to cause depression of cardiac function, especially during ischaemic conditions. Chronic beta-blockade in patients with primary congestive cardiomyopathy improved both cardiac function and clinical condition in more than half the patients. Furthermore, a beneficial effect on survival was also found, when compared with a matched control group. It is hypothesised that catecholamines may play a role in developing cardiac hypertrophy as well as congestive cardiomyopathy.
众所周知,心脏会通过不同机制增大或缩小其大小来适应实际需求。在本报告中,讨论了儿茶酚胺在调节心脏蛋白质合成以及发展为心脏肥大和心肌病方面可能发挥的作用。已发现给动物注射儿茶酚胺会诱发心脏肥大。已发现,在儿茶酚胺存在的情况下对大鼠心脏进行体外灌注会诱导氨基酸转运以及掺入蛋白质的时间依赖性和剂量依赖性刺激。儿茶酚胺的急性血流动力学效应可增强心脏功能,而长期治疗似乎会导致心脏功能抑制,尤其是在缺血情况下。原发性充血性心肌病患者的慢性β受体阻滞剂治疗使超过半数患者的心脏功能和临床状况得到改善。此外,与匹配的对照组相比,还发现对生存率有有益影响。据推测,儿茶酚胺可能在心脏肥大以及充血性心肌病的发展中起作用。